Antiphosphotipid Antibodies,β2-Glycoprotein I and Thrombosis

Wasserman A. Uber die Entwicklung und den gegenwartigen Stand der Serodiagnostik gegenuber syphilis. Berl Klin Wchnschr 1907; 44: 1599.

Pangbom MC A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 1941; 48: 484-6.

Moore JE , Mohr CF Biologically false positive serologic tests for syphilis. JAMA 1952; 150: 467-73.

Moore JE , Lutz WB The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors. J Chron Dis 1955; 1: 297-316.

McNeil HP , Chesterman CN , Krilis SA Immunology and clinical importance of antiphospholipid antibodies . Adv Immunol 1991; 49: 193-280.

Harris EN , Gharavi AE , Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-14.

Harris EN , Gharavi AE , Hughes GR Anticardiolipin antibody testing: the need for standardization. Arthritis Rheum 1987; 30: 835-7 (letter).

Love PE , Santoro SA Antiphospholipid antibodies: anticardioligin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990 ; 112: 682-98.

Harris EN , Gharavi AE , Wasley GD , Hughes GR Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988 ; 157: 23-31.

Feinstein DI , Rapaport SI Acquired inhibitors of blood coagulation . Prog Haemostas Thromb 1972; 1: 75-95.

Exner T. , Rickard KA , Kronenberg H. A sensitive test demonstrating lupus anticoagulatn and its behavioural patterns . Br J Haematol 1978; 40: 143-51.

Vaarala O. , Palosuo T. , Kleemola M. , Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41: 8-15.

Manoussakis MN , Gharavi AE , Drosis AA , Kitridou RC , Moutsopoulos HM Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immuraopathol 1987; 44: 297-307.

Lockshin MD , Druzin ML , Goei S. et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus . N Engl J Med 1985; 313: 152-6.

McNeil HP , Chesterman CN , Krilis SA Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 1989; 73: 506-13.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.

Galli M. , Comfurius P. , Maassen C. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335: 1544-7.

Matsuura E. , Igarashi Y. , Fujimoto M. , Ichikawa K. , Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990 ; 336: 177-8 (letter).

Oosting JD, Derksen RHWM, Entjes HTI, Bouma BN, de Groot PG. Lupus anticoagulant activity is frequently dependent on the presence of %-glycoprotein I. Thromb Haemostas 1992; 67: 499-502.

Bevers EM , Galli M. , Barbui T. , Comfurius P. , Zwaal RF Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.

McNeil HP , Hunt JE , Krilis SA New aspects of anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 525-7.

Hunt JE , McNeil HP , Morgan GJ , Crameri RM , Krilis SA A phospholipid-β2-Glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 83-90.

Harris NE , Pierangeli S. What is the 'true' antigen for antiphospholipid antibodies? Lancet 1990; 336: 1505 (letter; comment).

Shoenfeld Y. , Meroni PL The beta-2-glycoprotein I and antiphospholipid antibodies. Clin Exp Rheumatol 1992; 10: 205-9.

Hunt JE , Simpson RJ , Krilis SA Identification of a region of Byglycoprotem I critical for lipid-binding and anticardiolipin antibody cofactor activity. Proc Natl Acad Sci USA 1993; 90: 2141-5.

Pierangeli SS , Harris EN , Davis SA , DeLorenzo G. Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies . Br J Haematol 1992; 82: 565-70.

Kato H. , Enjyoji K. Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. Biochemistry 1991; 30: 11687-94.

Steinkasserer A. , Estaller C. , Weiss EH , Sim RB , Day AJ Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochem J 1991; 277: 387-91.

Matsuura E. , Igarashi Y. Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992 ; 148: 3885-91.

Arvieux J. Roussel B , Jacob MC , Colomb MG Measurement of antiphospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223-9.

Viard JP , Amoura Z. , Bach JF Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J. Med 1992; 93: 181-6.

Bancsi LF , van-der-Linden IK , Bertina RM Beta 2-glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 1992; 67: 649-53.

Matsuda J. , Wakabugi K. , Saitoh N. , Tsukamoto M. , Miyajima Y. , Kazama M. Low beta 2-glycoprotein I levels in patients with disseminated intravascular coagulation. Am J Hematol 1993; 42: 234-5.